Skip to main content

Table 7 Estimated Percentage of BMS and CABG Patients who Should Receive DES by Year Following DES Approval*

From: Changing treatment patterns for coronary artery revascularization in Canada: the projected impact of drug eluting stents

  Mean Median Min Max
% of Patients Who Should Receive DES, 1st Year Following Approval
Bare metal stent patients 42.8% 30.0% 5.1% 100.0%
CABG patients 16.8% 10.0% 5.0% 50.0%
% of Patients Who Should Receive DES, 2nd Year Following Approval
Bare metal stent patients 56.0% 50.0% 10.2% 100.0%
CABG patients 25.5% 20.0% 5.0% 80.0%
% of Patients Who Should Receive DES, 3rd Year Following Approval
Bare metal stent patients 70.1% 90.0% 30.0% 100.0%
CABG patients 31.4% 30.0% 5.0% 90.0%
% of Patients Who Should Receive DES, 4th Year Following Approval
Bare metal stent patients 79.7% 90.0% 40.6% 100.0%
CABG patients 37.8% 35.0% 5.0% 90.0%
% of Patients Who Should Receive DES, 5th Year Following Approval
Bare metal stent patients 86.8% 90.0% 60.8% 100.0%
CABG patients 43.7% 40.0% 5.0% 90.0%
  1. *In answering this question, respondents were asked to assume that funding for DES was available. All questions were responded to by all 11 members of the study panel.